# iBreastExam — Breast Health for all > Radiation-free, clinically validated breast examination technology for early cancer detection. (iPhone/iPad app by UE LifeSciences Inc.) - Source: https://appshunter.io/ios/app/ibreastexam/id1621277982 (this page in markdown: same URL + `.md`) - Developer: [UE LifeSciences Inc](https://appshunter.io/developer/1615958204) - Category: Medical - Price: Free - Rating: 5.00/5 from 5 App Store ratings - Age rating: 17+ - Requires: iOS 15.6 · 182 MB - Languages: American English - Released: 2023-05-16 - Data updated: 2026-08-29 - Monetization: free - User reviews in markdown: https://appshunter.io/ios/app/ibreastexam/id1621277982/reviews.md ## What is iBreastExam? iBreastExam, is a hand-held, battery powered wireless medical technology that enables affordable and radiation-free breast examination and documentation at the point of care. iBreastExam is clinically validated across multiple independent studies with 7,500 women enrolled. iBreastExam is market cleared by a number of regulators globally including the US FDA, CE Mark and others. Over 500,000 women in 10 countries have received iBreastExam and hundreds of early cancer cases are identified with its help. iBreastExam has received the World Bank’s 2022 Global Women’s Healthtech Award, Innovative Health Technology recognition from the World Health Organization (WHO) and Thought Leader recognition at the 2021 Annual Meeting of the American College of Obstetricians and Gynecologists (by ACOG TV). The makers of iBreastExam, UE LifeSciences, is a women’s health company focused on preventive oncology. It designs, develops and commercializes medical technology solutions that enable early detection of leading cancers in women. Disclaimer: Please seek doctor’s advice in addition to using this app and before making any medical decisions. ## Key features - Radiation-free breast examination - Point-of-care documentation - Clinically validated technology - Early cancer case identification - Global regulatory clearance (FDA, CE Mark) - Award-winning healthtech ## Frequently asked questions about iBreastExam ### What is iBreastExam? iBreastExam is a hand-held, battery-powered wireless medical technology designed for affordable and radiation-free breast examination and documentation at the point of care. It has been clinically validated in studies involving 7,500 women and is market cleared by regulators like the US FDA and CE Mark. ### How many women have used iBreastExam? Over 500,000 women in 10 countries have received examinations using iBreastExam. The technology has been instrumental in identifying hundreds of early cancer cases. ### Is iBreastExam safe to use? Yes, iBreastExam is designed to be radiation-free, making it a safe option for breast examinations. It is a medical technology that has received global regulatory clearance, including from the US FDA. ### What awards has iBreastExam received? iBreastExam has received significant recognition, including the World Bank’s 2022 Global Women’s Healthtech Award, Innovative Health Technology recognition from the World Health Organization (WHO), and Thought Leader recognition at the 2021 Annual Meeting of the American College of Obstetricians and Gynecologists. ### Does iBreastExam require a doctor's consultation? Yes, the developers advise seeking a doctor's advice in addition to using iBreastExam and before making any medical decisions. It is a tool to aid in examination and documentation, not a replacement for professional medical consultation. ### What devices does iBreastExam support? iBreastExam is supported on iPhone, iPad, and iPod devices. It is developed by UE LifeSciences Inc, a company focused on preventive oncology and early cancer detection in women. ### When was the latest version of iBreastExam released? The latest version of iBreastExam, version 1.4.16, was last updated on May 27, 2026. The app was initially released on May 16, 2023. ### What is the age rating for iBreastExam? iBreastExam has an age rating of 17+. This indicates it is intended for adult users and may contain content or functionality suitable for this age group. ## Version history (last 5 releases) ### 1.4.26 — 2026-08-19 Various Bug Fixes and Enhancements ### 1.4.16 — 2026-05-27 Various Bug Fixes and Enhancements ### 1.3.99 — 2026-03-02 Various Bug Fixes and Enhancements ### 1.3.98 — 2026-01-14 - The scan page design has been updated to improve the visibility of the breast grid. - The Share icon is now visible after selecting multiple reports for easier access. - The app is now available in French and Russian. - The About Application section now displays the last sync timestamp. ### 1.3.94 — 2025-10-08 Various Bug Fixes and Enhancements ## Apps similar to iBreastExam | App | Rating | Price | Category | | --- | --- | --- | --- | | [MDCalc Medical Calculator](https://appshunter.io/ios/app/mdcalc-medical-calculator/id1001640662) | 4.9 (51,857) | Free | Medical | | [MediSearch AI](https://appshunter.io/ios/app/medisearch-ai/id6473300940) | 4.6 (176) | Free | Medical | | [AMBOSS Medical Knowledge](https://appshunter.io/ios/app/amboss-medical-knowledge/id1169487026) | 4.9 (13,629) | Free | Medical | | [Ped(z) - Pediatric Calculator](https://appshunter.io/ios/app/pedz-pediatric-calculator/id498776330) | 4.0 (3) | Free | Medical | | [OWise - Breast Cancer Support](https://appshunter.io/ios/app/owise-breast-cancer-support/id558158100) | 4.8 (5) | Free | Medical | | [Calculate by QxMD](https://appshunter.io/ios/app/calculate-by-qxmd/id361811483) | 4.8 (5,100) | Free | Medical | ## More apps by UE LifeSciences Inc - [CervAIcal](https://appshunter.io/ios/app/cervaical/id6475592618) - [OrCA - Oral Cancer](https://appshunter.io/ios/app/orca-oral-cancer/id6478955903) All apps by UE LifeSciences Inc: https://appshunter.io/developer/1615958204 ## Related topics [ibreastexam](https://appshunter.io/ios/topics/ibreastexam) --- *Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-08-29.*